Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Aniruddha Karve"'
Autor:
Clayton S. Lewis, Aniruddha Karve, Kateryna Matiash, Timothy Stone, Jingxing Li, Jordon K. Wang, Henri H. Versteeg, Bruce J. Aronow, Syed A. Ahmad, Pankaj B. Desai, Vladimir Y. Bogdanov
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
In 2021, pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer deaths in the United States. This is largely due to a lack of symptoms and limited treatment options, which extend survival by only a few weeks. There is thus an urge
Externí odkaz:
https://doaj.org/article/29da4e30511e47c1adfd8b98dcba50e7
Autor:
Abigail Koehler, Aniruddha Karve, Pankaj Desai, Jack Arbiser, David R. Plas, Xiaoyang Qi, Renee D. Read, Atsuo T. Sasaki, Vaibhavkumar S. Gawali, Donatien K. Toukam, Debanjan Bhattacharya, Laura Kallay, Daniel A. Pomeranz Krummel, Soma Sengupta
Publikováno v:
Pharmaceuticals, Vol 14, Iss 2, p 99 (2021)
Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor. The current standard of care for GBM is the Stupp protocol which includes surgical resection, followed by radiotherapy concomitant with the DNA alkylator temozolomide; however,
Externí odkaz:
https://doaj.org/article/828b4f2787c44da2b744a2df9d8086fd
Autor:
Donatien Kamdem Toukam, Debanjan Bhattacharya, Vaibhavkumar Gawali, Laura Kallay, Aniruddha Karve, Pankaj Desai, James Cook, Taukir Ahmed, Trajan Dan Ionascu, Susheela Tridandapani, Daniel Pomeranz Krummel, Soma Sengupta
Publikováno v:
Neuro-Oncology. 24:vii246-vii247
Standard-of-care for melanoma brain metastases is moving to stereotactic radiosurgery (SRS) with immunotherapy. Although this combined approach shows improved patient survival, the responses are not durable. SRS can also cause adverse reactions such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ed789466c99a501dd2ba83a097df95e
https://doi.org/10.1093/neuonc/noac209.953
https://doi.org/10.1093/neuonc/noac209.953
Autor:
Aniruddha Karve, Taukir Ahmed, Janki Desai, Debanjan Bhattacharya, Donatien Kamdem Toukam, Sidharth Gadgil, Merissa Pemberton, David Plas, Gary Gudelsky, Larry Sallans, James Cook, Pankaj Desai, Daniel Pomeranz Krummel, Soma Sengupta
Publikováno v:
Neuro-Oncology. 24:vii232-vii233
PURPOSE AMLAL-101 is a novel agent which preferentially targets α3, α5 subtypes of ɣ-amino butyric acid receptors and shows anti-tumor activity against disparate cancer types. AMLAL-101 is being advanced as an ‘add-on’ to potentiate treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c1c62ccde39f02127ea14bb46c4bf2c
https://doi.org/10.1093/neuonc/noac209.897
https://doi.org/10.1093/neuonc/noac209.897
Autor:
Timothy Rice, Molly Droege, Carolyn Philpott, Joshua Courter, Pankaj Desai, Nicole Harger, Neil Ernst, Madeline Foertsch, Daniel Healy, Aniruddha Karve, Siyun Liao, Eric Mueller, Jessica Winter, Michael Goodman, Chris Droege
Publikováno v:
Critical Care Medicine. 51:642-642
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e203aebb7bb7a311cc79ba84e0c2ff29
https://doi.org/10.1097/01.ccm.0000910880.97506.4f
https://doi.org/10.1097/01.ccm.0000910880.97506.4f
Autor:
Debanjan Bhattacharya, Riccardo Barille, Donatien Kamdem Toukam, Vaibhavkumar Gawali, Laura Kallay, Taukir Ahmed, James Cook, Aniruddha Karve, Pankaj Desai, Mario Medvedovic, Daniel Pomeranz Krummel, Soma Sengupta
Publikováno v:
Neuro-Oncology. 24:vii247-vii247
Most advanced-stage non-small cell lung cancer (NSCLC) patients have brain metastases that render a dismal prognosis. Treatment of metastatic brain lesions from NSCLC and other tumor types include radiation as part of a multimodal treatment regimen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3539761b656ec7408395f797a0c1caf
https://doi.org/10.1093/neuonc/noac209.954
https://doi.org/10.1093/neuonc/noac209.954
Autor:
Aniruddha Karve, Janki Desai, Nimita Dave, Timothy Phoenix, Gary Gudelsky, David Plas, Biplab Dasgupta, Trisha Wise-Draper, Pankaj Desai
Publikováno v:
Neuro-Oncology. 24:vii233-vii233
PURPOSE Despite significant advances in multimodal approaches for the treatment of glioblastoma (GBM), the outcome for the patients remains dismal. Previous research from our lab has shown that aromatase (CYP19A1), an enzyme that catalyzes in situ pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3b098dfc0e51f9172106c4b00e66bf8
https://doi.org/10.1093/neuonc/noac209.899
https://doi.org/10.1093/neuonc/noac209.899
Autor:
Pankaj B. Desai, Clayton S. Lewis, Jingxing Li, Aniruddha Karve, Syed A. Ahmad, Vladimir Y. Bogdanov, Henri H. Versteeg, Jordon K Wang, Kateryna Matiash, Timothy Stone, Bruce J. Aronow
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology, 11. FRONTIERS MEDIA SA
Frontiers in Oncology
Frontiers in Oncology, 11. FRONTIERS MEDIA SA
In 2021, pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer deaths in the United States. This is largely due to a lack of symptoms and limited treatment options, which extend survival by only a few weeks. There is thus an urge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d826e7d52b7862be0b4dd70186729c34
https://hdl.handle.net/1887/3230170
https://hdl.handle.net/1887/3230170
Autor:
Samar Alanazi, Hima Patel, Pankaj B. Desai, Joan T. Garrett, Aaron White, Long Yuan, Aniruddha Karve, Haizhou Zhu, Rosalin Mishra, Edward J. Merino
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2088, p 2088 (2021)
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2088, p 2088 (2021)
RIDR-PI-103 is a novel reactive oxygen species (ROS)-induced drug release prodrug with a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103). Under high ROS, PI-103 is released in a controlled manner to inhibit PI3K. The efficacy and bioava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9869e6675ebb7d1d107357e56b7341
Autor:
Renee Read, Donatien K Toukam, Soma Sengupta, Abigail Koehler, Xiaoyang Qi, Aniruddha Karve, David R. Plas, Vaibhavkumar S. Gawali, Daniel Pomeranz Krummel, Jack L. Arbiser, Atsuo T. Sasaki, Laura Kallay, Pankaj B. Desai, Debanjan Bhattacharya
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 99, p 99 (2021)
Pharmaceuticals, Vol 14, Iss 99, p 99 (2021)
Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor. The current standard of care for GBM is the Stupp protocol which includes surgical resection, followed by radiotherapy concomitant with the DNA alkylator temozolomide; however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9196b1d938b3e98fdc8e750a1322e88e
https://pubmed.ncbi.nlm.nih.gov/33525329
https://pubmed.ncbi.nlm.nih.gov/33525329